However, Shin et al. (13) have investigated the effects of butyrate in human gastric cancer cells, where aberrant Wnt pathway activity also occurs, and found that treatment with butyrate restored SFRP1 expression, which correlated with promoter demethylation (13). The gene discussed is SFRP1; the disease is gastric cancer.